Last month, a patient I will call Sunita sat across from me with the kind of frustration I hear often in weight-management consultations: the initial drop after a new diet plan, followed by regain, heaviness, fatigue, and the feeling that the body is resisting every effort.

For patients like this, Ayurveda does not look at weight only as a number on the scale. It looks at Meda Dhatu, Agni, Kapha, food habits, sleep, daily movement, bowel pattern, appetite, stamina, and the person’s constitutional pattern. That is why the 2025 clinical trial on Vyoshadi Guggulu and Vidanga Churna is worth examining carefully: it evaluated an Ayurvedic approach to obesity while also recording Ayurvedic clinical parameters.

The Trial: What They Actually Tested

Sanjay Kumar Giri and colleagues published a prospective, multicentre, open-label, single-arm clinical study in Global Advances in Integrative Medicine and Health in 2025. The trial evaluated the safety and efficacy of two Ayurvedic formulations, Vyoshadi Guggulu and Vidanga Churna, in individuals with obesity.

The intervention used in the trial was:

  • Vyoshadi Guggulu (VSG): 1 gram three times daily after food with lukewarm water
  • Vidanga Churna (VDC): 3 grams twice daily after food

The trial recruited 100 participants across two CCRAS centres, the Central Ayurveda Research Institute in Bengaluru and M.S. Regional Ayurveda Research Institute in Jaipur. Eighty-six participants completed the study, and the intervention period lasted 12 weeks, followed by a 2-week follow-up without medication.

What makes the study clinically interesting is that it did not treat obesity as only a body-weight endpoint. Ayurvedic evaluation included Prakriti, Agni, Meda Dhatu, Ahara Shakti, Satmya, Saara, Satva, and Vyayama Shakti. These are not decorative terms in Ayurveda; they shape how a practitioner understands the pattern behind excess Meda and how strongly a person can tolerate diet, exercise, and herbal intervention.

The Numbers That Matter

The trial reported statistically significant improvements in BMI, waist circumference, total serum cholesterol, and LDL cholesterol. Body weight decreased numerically, but that change was not statistically significant, and DEXA scan values did not show a statistically significant change during the study period.

Parameter Reported change P-value
BMI 29.99 ± 4.392 to 29.64 ± 3.228 P = 0.016
Waist circumference 100.32 ± 7.810 cm to 97.93 ± 7.600 cm P = 0.043
Body weight 77.93 ± 11.321 kg to 75.83 ± 10.799 kg P = 0.113
Total serum cholesterol 176.56 ± 36.590 mg/dL to 164.71 ± 44.653 mg/dL P = 0.002
LDL cholesterol Significant reduction P = 0.033

The practical reading is important: the trial supports a favourable direction in BMI, abdominal measurement, and lipid parameters, but it does not prove major weight loss. It is best read as supportive evidence for a complementary Ayurvedic metabolic approach, not as proof that the formulations alone are a complete obesity treatment.

The safety finding is also clinically meaningful. No adverse drug reactions or adverse events were reported during the study period. At the same time, the study design was open-label and single-arm, so longer, controlled trials are still needed before making broad claims about long-term efficacy and safety.

Why These Herbs? The Ayurvedic Logic

Ayurveda describes obesity under terms such as Sthaulya, Atisthaulya, and Medoroga. In Charaka Samhita, Sutra Sthana Chapter 21, excessive obesity is included among the eight undesirable physical constitutions. Charaka describes causes such as over-nourishment, heavy, sweet, cold, unctuous diet, lack of exercise, daytime sleep, and hereditary tendency, with excess Meda becoming prominent.

Among the bodily types described in Charaka’s Ashtauninditiya chapter, the excessively obese and the excessively lean are given special attention because of their clinical consequences.

In Ayurvedic reasoning, Medoroga is not reduced to overeating alone. A person may have excess Kapha, disturbed Meda Dhatu, obstructed channels, poor daily movement, irregular appetite patterns, unsuitable diet, and impaired tissue-level transformation. A useful protocol must therefore support Agni, reduce Kapha-Meda accumulation, improve bowel and appetite patterns, and include movement appropriate to the person’s strength.

Vyoshadi Guggulu

Vyoshadi Guggulu is a classical polyherbal Guggulu formulation listed in the Ayurvedic Formulary of India and referenced in the trial as standardized according to AFI Part I and API Part II. In the trial, each dose was 1 gram, given as two 500 mg tablets, three times daily after food.

From an Ayurvedic perspective, Vyoshadi Guggulu is used where Kapha, Meda, heaviness, and sluggish metabolic function are central features. The trial article describes it as a formulation used in obesity, joint disorders, and metabolic imbalance, with traditional actions directed toward lipid metabolism, Kapha reduction, and Meda Dhatu regulation.

Vidanga Churna

Vidanga Churna is prepared from Vidanga, identified botanically as Embelia ribes. The trial used Vidanga Churna in a dose of 3 grams twice daily after food and notes that the formulation was prepared according to the Ayurvedic Pharmacopoeia of India.

Classically, Vidanga is especially known for Krimighna action, but it is also used in digestive and metabolic contexts. In this trial, its pairing with Vyoshadi Guggulu reflects an Ayurvedic attempt to address not only stored Meda but also digestion, gut-related disturbance, and Kapha-Meda accumulation.

Shunthi and Haritaki Within the Formulation Logic

The trial article identifies Vyoshadi Guggulu as a polyherbal preparation containing ingredients such as Guggulu, Shunthi, and Haritaki. Shunthi, or dry ginger, is valued in Ayurveda for supporting Agni and clearing heaviness. Haritaki is widely used in classical practice for bowel regulation, Rasayana-oriented support, and the management of accumulated metabolic heaviness when selected appropriately.

The clinical logic is therefore not a random mixture of herbs. Guggulu-centred formulations are traditionally used where scraping, mobilizing, and Kapha-Meda reduction are needed; Shunthi supports digestive fire; Haritaki supports bowel movement and channel cleansing; Vidanga adds digestive and Krimighna-oriented support.

What This Means for Practice

One clinical trial should not be turned into a miracle claim. This trial was not placebo-controlled, not blinded, and not designed to isolate the independent effect of each herb. It also did not show statistically significant body-weight reduction, DEXA improvement, or quality-of-life improvement during the measured period.

What it does provide is a useful clinical signal: when Vyoshadi Guggulu and Vidanga Churna were given in the specified doses for 12 weeks, participants showed significant improvement in BMI, waist circumference, total cholesterol, and LDL cholesterol, with no reported adverse drug reactions or adverse events during the study period.

For an Ayurvedic practitioner, the most useful part is not only the numerical change. It is the integration of Ayurvedic assessment with measurable metabolic outcomes. Prakriti, Ahara Shakti, Satmya, Saara, Satva, and Vyayama Shakti help clarify why two people with the same BMI may need different levels of diet restriction, different exercise intensity, different herbal choices, and different follow-up intervals.

A Practical Framework With Caveats

For a Kapha-Meda-predominant presentation, a practitioner may consider a framework built around warm, light, Kapha-pacifying food, daily movement, correction of daytime sleep, and carefully selected formulations. The trial dose was Vyoshadi Guggulu 1 gram three times daily after food with lukewarm water and Vidanga Churna 3 grams twice daily after food, but this should not be copied as a self-prescription.

  • Assessment first: Prakriti, Vikriti, Agni, bowel habit, appetite, sleep, waist measurement, lipid profile, blood glucose status, medications, and exercise capacity should be reviewed.
  • Diet direction: Reduce heavy, oily, cold, excessively sweet foods and favour warm, freshly prepared, lighter meals suited to the person’s strength and digestion.
  • Movement: Daily exercise is central in Ayurvedic weight management, but the intensity should match Vyayama Shakti and cardiovascular status.
  • Monitoring: Weight, waist circumference, energy, bowel pattern, lipids, blood glucose markers, liver function, kidney function, and medication interactions should be monitored where relevant.

Important safety note: Guggulu-containing formulations may not be suitable for everyone. People taking prescription medicines, especially thyroid medicines, anticoagulants, cardiovascular medicines, diabetes medicines, or drugs metabolized through CYP pathways, should consult a qualified Ayurvedic practitioner and their healthcare provider before using these formulations. Pregnant or lactating individuals, people with significant liver or kidney disease, and anyone with complex chronic illness should not self-prescribe.

Back to the Patient Who Feels Stuck

For a patient like Sunita, the lesson is not that one pill fixes obesity. The lesson is that Ayurveda gives a framework for understanding why the body may keep storing, why appetite and fatigue may fluctuate, why waist measurement may matter as much as the scale, and why digestion, sleep, movement, and Meda Dhatu must be treated together.

The 2025 trial gives more confidence in a carefully supervised use of Vyoshadi Guggulu and Vidanga Churna as part of an Ayurvedic obesity-management plan. It does not replace individualized assessment, diet, exercise, or medical care. The best use of this evidence is thoughtful integration: classical reasoning, modern monitoring, and a plan tailored to the person rather than the supplement shelf.

References

  1. SAGE Journals
  2. Charaka Samhita — Ashtauninditiya Adhyaya
  3. Mskcc (mskcc.org)
  4. NCCIH
Tags: Ayurvedic weight management BMI Guggulu Kapha dosha obesity Vidanga weight loss